BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33775465)

  • 1. Revisiting Richter transformation in the era of novel CLL agents.
    Petrackova A; Turcsanyi P; Papajik T; Kriegova E
    Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
    Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
    Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clonality relatedness and molecular characteristics of Richter transformation].
    Sha YQ; Jiang R; Miao Y; Qiu TL; Qin SC; Qiu JY; Mi HL; Wu W; Qiao C; Wu YJ; Xia Y; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):841-847. PubMed ID: 36709198
    [No Abstract]   [Full Text] [Related]  

  • 5. Richter transformation of CLL.
    Jain N; Keating MJ
    Expert Rev Hematol; 2016 Aug; 9(8):793-801. PubMed ID: 27351634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
    Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
    Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia.
    Innocenti I; Rossi D; Trapè G; Autore F; Larocca LM; Gomes V; Cerri M; Falcucci P; Sica S; Gaidano G; Laurenti L
    Hematol Oncol; 2018 Feb; ():. PubMed ID: 29484684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Richter's Syndrome.
    Condoluci A; Rossi D
    Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Richter transformation of chronic lymphocytic leukemia in the era of novel agents.
    Wang Y; Ding W
    Clin Adv Hematol Oncol; 2020 Jun; 18(6):348-357. PubMed ID: 32649656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents.
    Tadmor T; Levy I
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma.
    Buckley T; Inamdar A; Mikhail NH; Loo A; Cohen S
    Am J Case Rep; 2021 Dec; 22():e932904. PubMed ID: 34934038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Richter syndrome: pathogenesis and management.
    Rossi D; Gaidano G
    Semin Oncol; 2016 Apr; 43(2):311-9. PubMed ID: 27040710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Lysis Syndrome Caused by Unrecognized Richter's Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression.
    Chango Azanza JJ; Calle Sarmiento PM; Mathew Thomas V; Lopetegui Lia N; Kidwai N
    Cureus; 2020 May; 12(5):e8145. PubMed ID: 32550064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
    Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.